Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization
- PMID: 1898886
- DOI: 10.1016/s0015-0282(16)54070-9
Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization
Abstract
The impact of pituitary suppression with a gonadotropin-releasing hormone agonist (GnRH-a) on the luteal phase of in vitro fertilization (IVF) cycles was examined in 21 women who underwent identical stimulation regimens with and without leuprolide acetate pretreatment. The areas under the serum progesterone curves, measured over the 1st 10 days of the luteal phase, were significantly greater in the GnRH-a cycles compared with the non-GnRHa cycles, but when calculated per oocyte retrieved were similar in GnRH-a and non-GnRH-a cycles. In contrast, the areas under the luteal phase serum estradiol curves were significantly less in the GnRH-a cycles. These data suggest that GnRH-a treatment is accompanied by potentially beneficial alterations in the systemic steroidal milieu of the luteal phase of IVF cycles.
Similar articles
-
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953. J Clin Endocrinol Metab. 2003. PMID: 12970285 Clinical Trial.
-
Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.Hum Reprod. 1991 Feb;6(2):206-13. doi: 10.1093/oxfordjournals.humrep.a137307. Hum Reprod. 1991. PMID: 1905309
-
Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.Fertil Steril. 1989 Feb;51(2):292-7. doi: 10.1016/s0015-0282(16)60493-4. Fertil Steril. 1989. PMID: 2492234 Clinical Trial.
-
Gonadotropin-releasing hormone antagonists: effects on the ovarian follicle and corpus luteum.Clin Obstet Gynecol. 1993 Sep;36(3):744-52. doi: 10.1097/00003081-199309000-00031. Clin Obstet Gynecol. 1993. PMID: 8403621 Review. No abstract available.
-
Luteal-phase support in assisted reproductive technology: An ongoing challenge.Int J Reprod Biomed. 2021 Oct 10;19(9):761-772. doi: 10.18502/ijrm.v19i9.9708. eCollection 2021 Sep. Int J Reprod Biomed. 2021. PMID: 34723055 Free PMC article. Review.
Cited by
-
Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques.J Assist Reprod Genet. 1994 Feb;11(2):85-91. doi: 10.1007/BF02215993. J Assist Reprod Genet. 1994. PMID: 7819707 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources